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Hormonal measurement in psychobiological research.
Three peripherally circulating hormones that can be measured in saliva have 
received growing attention in psychobiology research. Cortisol and 
dehydoepiandrosterone (DHEA) are steroid hormones indicative of activity in the 
hypothalamic-pitutary-adrenal (HPA) axis.  The third, the methoxyindole melatonin, is 
the hormonal product of the pineal neuroendocrine system.  The development of 
reliable methods for salivary hormone assessment was a key turning point for 
psychobiology research as it enabled new approaches to the study of a wide range 
of individual difference factors. These biological indices provide meaningful objective 
measures that can be analysed in parallel to self-reported variables (e.g. stress/well-
being) as well as sociodemographic, developmental, psychological and health 
variables. Saliva is an easy to access biological fluid, collection of which is 
convenient and does not require trained personnel.  Indeed participants can be 
shown how to undertake self-collection of samples which enables repeated sampling 
in ambulatory studies (with resultant ecological validity) as well as experimental 
manipulations within the laboratory. The purpose of this chapter is to guide the 
psychobiology researcher on appropriate approaches and methodologies for using 
salivary hormone measures for meaningful investigation of a virtually limitless range 
of potential research questions. 
Physiology 
Together the three hormones reviewed in this chapter perform wide ranging and 
complex physiological roles; their study provides a remarkable insight in individual 
2differences in human functioning. Cortisol enables adjustment to a wide range of 
bodily and environmental demands (Fries et al., 2009).  For example acute 
psychological demand (e.g. psychosocial stress) increases cortisol levels in a dose-
response manner (Dickerson and Kemeny, 2004). Cortisol exerts powerful effects on 
the immune and cardiovascular (CV) systems, metabolism, mood and cognition (to 
name just a few). DHEA is associated with physical, sexual and emotional 
development as well as metabolism, CV function and memory.  Melatonin is the 
main hormone of the night as it promotes sleep, it is also a power antioxidant and 
helps regulate the immune system and mood. So individual differences in the 
secretion of these hormones can provide insight into subtle changes in 
psychobiological function. These changes may not, at time of measurement, have 
translated into observable symptoms but may indicate vulnerability to clinical 
symptoms, should the changes be sustained.  As such these hormone measures 
provide a useful pre-clinical indicator of the links between mind and body. 
The hypothalamic-pituitary-adrenal (HPA) axis is a major neuroendocrine system; 
one of the pathways by which the brain can exert control over aspects of internal 
physiological activity. It is hierarchical in its organisation.  The neural control centre is 
the hypothalamus, a region of the brain located below the thalamus within the limbic 
system, our emotional brain.  The hypothalamus receives neuronal input from 
various modalities including the cognitive and emotional brain as well as visual 
information denoting dark-light transitions. In terms of its regulation over the HPA 
axis the paraventricular nuclei (PVN) of the hypothalamus performs a central role.  In 
response to activating input signals the parvocellular cells of the PVN secrete a 
neuropeptide, corticotropin releasing factor (CRF) which in turn stimulates the 
release of adrenocorticotrophic hormone (ACTH) from corticotrophs in the anterior 
pituitary, an endocrine gland that sits just below the hypothalamus.  ACTH is 
released into the general circulation as a hormone, to stimulate steroidogenic activity 
and peripheral hormone release from the adrenal cortex.  Hence the hierarchical 
nature of the HPA axis.
In common with other patterns of anterior pituitary activity the HPA axis is pulsatile. 
Secretory episodes occurring at roughly hourly intervals.  This is apparent for ACTH 
3and consequent cortisol secretion and likely reflects the activity of pulse generation 
in the hypothalamus.  Pulsatile patterns of secretion are only evident in individual 
profiles based upon frequent (or continuous) blood sampling. They are lost for the 
majority of sampling protocols (including salivary sampling) and when data from 
multiple individuals is summed to reveal overall trends.  The importance of pulsatility 
in cortisol function is attracting increasing attention, most notably by 
neuroendocrinologists studying animal models (e.g. Lightman and Conway-
Campbell, 2010) however, although it is important to be aware of this interesting 
emerging area, analysis of hormone pulsitity is not possible in saliva samples and is 
hence beyond the scope of the majority of psychobiologists.
Accurate and meaningful assessment of cortisol in saliva samples was the first of 
these hormones to be validated (see Kirschbaum and Hellhamer 1989).  
Consequently salivary cortisol is the most intensively studied, however interest in 
salivary DHEA is substantial and is gradually gathering ground for salivary 
melatonin.  Cortisol is a lipid-soluble hormone and passes freely through cellular 
plasma membranes.  In the blood circulation it is mostly bound to plasma proteins, a 
specific cortisol binding globulin termed ‘transcortin’ and to some extent albumin. 
Some 90% of blood cortisol is protein bound, mostly to transcortin.  This serves to 
transport the molecule in the circulation and also acts as a reservoir.  At target tissue 
a dynamic equilibrium will operate between circulatory protein-bound steroid, free 
cortisol and cortisol receptors expressed within the cells.  Only free cortisol is 
biologically active; available for receptor binding.  Blood cortisol assay measures 
total cortisol in a sample with no distinction between bound and free.  Over the past 
several decades and particularly in psychobiology research the body fluid of choice 
for cortisol assessment has been saliva.  As previously mentioned this medium 
provides the obvious advantage of sampling convenience, which can be done simply 
by the participant without clinical attention or trauma and at repeated intervals of 
close proximity over the time course of a study interest. Additionally saliva contains 
only the free component of circulating cortisol, since free cortisol equilibrates across 
the membrane barriers of the salivary gland.  Salivary cortisol is a convenient 
measure of circulating free cortisol.  In this it provides a more sensitive index of 
endocrine signalling within the HPA axis, not encumbered by the large amounts of 
4protein bound steroid circulating inactively. In an analogous way much of the DHEA 
in the blood circulation is conjugated as the sulphate (DHEA-S).  This forms a large 
reservoir, comparable to the protein bound cortisol component in blood.  
Unconjugated DHEA is physiologically active and this is the component usually 
reported as the salivary measure 
The adrenal cortex is composed of three distinct zones; the mid zone, zona 
fasciculate is the largest and synthesises and secretes the glucocorticoid cortisol. 
Inner to this is the zona reticularis which secretes the adrenal androgen DHEA 
whereas an outer zone, the zona glomerulosa produces mineralocorticoids primarily 
aldosterone. All are derived from the steroid precursor pregnenolone, itself derived 
from cholesterol.  The pathway of steroidogenesis depends upon the enzyme activity 
in each zone.  ACTH exerts its stimulatory influence at the early undifferentiated 
stage, cholesterol conversion to pregnenolone.  ACTH is thought the only 
secretagogue for cortisol and DHEA. Hence the HPA axis is the stimulatory axis for 
the two major peripheral steroid hormones cortisol and DHEA.  
A major difference between cortisol and DHEA activity is developmental.  Secretory 
patterns of cortisol are established in infancy and remain relatively stable throughout 
adult life, although disturbances are associated with older age, adverse life 
circumstances, physical and mental illnesses (see later). By contrast DHEA 
secretion is lacking in infancy and childhood up until near puberty. Preceding the 
onset of puberty (menarche in girls) by a year or so the adrenal undergoes a 
maturation, referred to as adrenarche, when the zona reticularis begins to secrete 
DHEA.  DHEA is responsible for the growth of pubic and axillary hair in both boys 
and girls, stimulates the prepubertal growth spurt and contributes to a shift in the 
focus of psychological attachment from parent to peer (Oskis et al., 2015).  DHEA 
secretion, continues to increase through adolescence and early adulthood until late 
twenties; declining from middle into older age.  
Melatonin is distinct from both cortisol and DHEA being synthesized from tryptophan, 
once taken up from the circulation and transformed to serotonin. Serotonin is 
converted into melatonin by a two-step process involving the sequential activities of 
5two enzymes, the rate-limiting serotonin-N-acetyl transferase, and hydroxyindole-O-
methyl transferase. Noradrenergic neurones stimulate pinealocytes in the pineal to 
secrete the hormone, which has high lipid and water solubility which facilitates 
passage across cell membranes enabling access to body fluids including saliva.  The 
peripheral hormone profile of melatonin faithfully reflects active secretion as no 
pineal storage of melatonin is available. The secretion of melatonin occurs almost 
exclusively at night in the dark, with maximum levels around 3:00-4:00 a.m.; diurnal 
levels are low and often undetectable (Claustrata et al, 2005). Maternal melatonin 
crosses the placenta and is one of the maternal rhythmic signals capable of 
synchronizing the fetal biological clock. After maturation, melatonin production 
reaches the highest levels at the age of 3-6 years. In contrast to DHEA melatonin 
secretion decreases with the onset of puberty (Crowley et al, 2012). With aging, the 
melatonin rhythm progressively dampens, and can be completely abolished in 
advanced age (Claustrata et al, 2005).
Circadian regulation
Healthy regulation of cortisol, DHEA, melatonin is overseen by the brain’s biological 
clock: the suprachiasmatic nucleus (SCN).  The SCN generates circadian (24 hour) 
secretory patterns of all three hormones. Using careful methodology as described 
below, daytime (diurnal) patterns are accessible to psychobiologists using saliva 
sampling. There is increasing evidence that aberrant circadian cycles are a common 
factor in a wide range of clinical mental and physical health conditions (Dickmeis et 
al, 2009; Wulff et al, 2010; Jagganarth et al, 2013).  By careful assessment of these 
hormones from saliva samples it is possible to gain an insight into circadian function 
of populations. However what makes this approach so worthwhile is that aberrant 
diurnal hormone can be detected in sub-clinical syndromes i.e. at risk populations 
can show aberrant diurnal hormone profiles prior to onset of symptoms (e.g. Oskis et 
al, 2011).  This is interesting as it suggests that dysfunction of circadian function may 
precede and predict pathology, rather than be a consequence thereof.  The diurnal 
profile of these hormones has been shown to be responsive to modification by 
interventions and can thus be used to evaluate changes in circadian physiology prior 
to observable change in symptomology. In other words the neuroendocrine system is 
6an excellent model for studying the transmission of circadian information in the body 
(Kalsbeek et al, 2012).
The SCN is located in the hypothalamus and is the body’s 24 hour endogenous 
oscillator (Kriegsfeld et al, 2003). Activity of genes within every cell of the SCN 
switch on and off over an approximately 24 hour period by using transcription-
translation feedback loops.  These genes generate proteins that send messages to 
surrounding cells controlling function – in this way the SCN has a powerful effect on 
brain and body function. The individual cells of the SCN are synchronised with each 
other and the external environment by a range of zeitgebers.  The most powerful of 
these cues is light; others include body temperature and social activities such as 
eating.  Light is a particularly powerful zeitgeber as the SCN is strategically located 
over the optic chiasmic (the crossing of the optic nerves) such that light messages 
from non-vision light receptors in the back of the retina (retinal ganglion cells) 
terminate there and inform the cells of the SCN of day and night.  Most bodily 
functions oscillate around the 24 hour day night cycle.   Aging and a wide range of 
psychopathology is associated with dysfunction in circadian function, which can be 
studied by careful examination of secretory patters of hormones from saliva samples.
Cortisol has a marked circadian pattern of secretion, with lowest levels (i.e. the nadir) 
a few hours after the onset of night-time sleep.  Levels gradually rise during the later 
phases of night-time sleep; the moment of awakening initiates a large burst in 
cortisol secretion, which is at its maximum when waking with ambient light (i.e. at 
dawn). The cortisol awakening response (CAR) generates the highest levels (i.e. the 
acrophase) in daily cortisol secretion, peaking between 30-45 minutes following 
morning awakening. Marked day differences in the size of the CAR have been 
reported; this particular aspect of the circadian pattern of cortisol secretion is 
particularly sensitive to daily variation in state variables such as ambient light and 
psychological state (Stalder et al, 2009; Clow et al, 2010). Following this peak there 
is a marked decline in cortisol and between 3 hours after awakening and bedtime 
there is a gradual decline in cortisol secretion, in readiness to bedtime and night-time 
sleep. The cortisol diurnal decline is not sensitive to light and daily variation in this 
aspect is less marked than for the CAR in healthy participants (Edwards et al, 2001).  
7The circadian secretory pattern of melatonin is the opposite to that of cortisol as it 
reaches its maximum during night-time sleep and is low or even absent during the 
day: melatonin secretion is inhibited by light (Vakkuri, 1985).  The relatively recent 
introduction of validated assays for the assessment of melatonin levels from saliva 
samples (Voultsios et al, 1997) means there is a more limited literature on the 
dynamics of melatonin secretion across the day using repeated saliva sampling.  
Most studies have utilised blood sampling, often at a single time point. Recently 
however it has been shown that the post-awakening pattern of melatonin secretion is 
consistent across days for healthy individuals.  However there is no melatonin 
equivalent of the CAR (Ramachandran et al, 2016): levels of melatonin gradually fall 
after awakening (29% in the first 45 minutes compared to a 112% rise in cortisol over 
the same post awakening period) and remain low until night-time sleep when there is 
a marked surge. Changes in, and levels of, post awakening cortisol and melatonin 
are reported to be unrelated. This is not surprising as the hormones originate from 
separate synthetic pathways, as described above. However there are reports that 
the amplitude of day-to-night changes in cortisol and melatonin are related 
(Corbalan-Tutau et al, 2014).
In contrast to melatonin the circadian pattern of DHEA secretion is more likely to be 
associated with cortisol as both hormones originate from the same gland, albeit 
discrete layers within that gland. Indeed as ACTH is the secretagogue of both 
cortisol and DHEA it is unsurprising that both hormones show similar circadian 
profiles: highest in the morning with decreasing levels during the day and night. 
Levels and patterns of DHEA secretion are remarkably consistent across days in 
healthy participants (Hucklebridge et al, 2005). However there is no observable post 
awakening surge in DHEA secretion; levels are highest upon awakening and remain 
stable during the first 45 minutes post awakening. DHEA levels do fall following 
awakening, reaching a diurnal low prior to sleep.  Another distinguishing feature 
between diurnal patterns of cortisol and DHEA is that post awakening DHEA strongly 
predicts daytime levels of that hormone whereas post awakening cortisol does not 
(Oskis et al, 2012).  It is argued that DHEA more closely reflects levels of the 
secretagogue ACTH (i.e. HPA axis activation) than cortisol, secretion of which is 
8dependent upon ACTH availability but is fine-tuned by direct sympathetic nervous 
system innervation to the zona fasciculate of the adrenal cortex (Buijs et al, 2003; 
Clow et al, 2010). 
Recommendations for hormone measurement 
A number of technical issues relating to salivary hormone measurement deserve 
consideration. Common illnesses (i.e. colds and flu) can affect the immune system 
and sensitivity of the HPA axis. Consequently participants should be advised to only 
continue with the requested saliva sampling if they are feeling symptom-free. Avoid 
testing on participants who are taking prescribed medications as these influence 
basal cortisol and DHEA (e.g. Granger et al., 2009; Kroboth et al., 1999). If testing 
on participants who are taking medication record these and control for this in 
statistical analysis. Exclude all participants with a diagnosed neuroendocrine 
disorder (e.g. Cushing’s and Addison’s disease; associated with over- and 
underproduction of cortisol, respectively). Exclude all participants taking steroid-
based medication (e.g. to alleviate asthma, Crohn’s disease, rheumatoid arthritis) as 
the medication will mask any endogenous patterns of cortisol secretion. Other 
common behaviours such as vigorous physical activity, meals, smoking, caffeine and 
alcohol consumption can all affect activity of the HPA axis and should be avoided 
(see Table 7.1 for additional information and references).
In early studies the most commonly used assay was commercial radioimmunoassay 
(RIA) originally developed for blood measurement.  Assay volumes were adjusted to 
increase sensitivity; cortisol in saliva is only 5-10% of total circulating cortisol.  More 
recently commercial assay kits developed specifically for saliva and covering the 
appropriate assay range have become available for all three hormones here 
discussed.  Enzyme linked immunosorbent assay (ELISA) has tended to supplant 
RIA.  Assays should be undertaken in duplicate to ensure accurate measurement; 
the percentage coefficient of variation (%CV) between duplicates should be reported 
and variation greater than 10% should be repeated to confirm accurate results. Each 
assay plate should also always run a low and high ‘control’ sample (i.e. samples of 
known concentration provided by the assay suppliers; again assayed in duplicate). 
9This enables analysis of inter-plate reliability, reported when publishing results and 
should be no more than 10%CV. 
Along with advances in measurement technique a number of saliva collection 
methodologies have been developed.  The simplest and in many ways the most 
practical for salivary cortisol assessment is the Salivette device.  This relies on a 
cotton dental role that is placed in the mouth for about a minute to absorb saliva.  It 
is transferred to a small collection vial then centrifuged to obtain a clear sample.  
Passive drool (typically using a small section of plastic straw, into an Eppendorf vial) 
is required when DHEA or melatonin is to be measured. Care should be taken when 
labelling saliva collection devices. Tubes can become wet and be stored for long 
periods, so robust clear labelling is essential. Samples should be frozen (-200C) as 
soon as possible after collection and so stored until assay.  In ambulatory studies 
participants are recommended to store in their home freezer as soon as is practical. 
Research suggests that salivary cortisol is relatively stable at room temperature for 
up to 5 days, after which concentrations begin to decline. If convenient samples can 
be mailed back to the researcher during this time period (Clements et al, 1998). 
Participants are instructed to take nil by mouth, other than water, and not to smoke 
for at least 30 min prior to sampling. Sample protocols should be designed to avoid 
proximity to meal times.
Assessment of hormonal circadian patterns
Repeated saliva sampling can enable accurate assessment of the dynamics of the 
diurnal secretory pattern of all hormones. Ecological validity can be enhanced by 
self-collection of saliva samples within the domestic setting.  Participants can be 
instructed (most efficiently in a face-to-face interview with the researcher) on the 
methods for saliva sampling and the requirement to adhere to strict timing 
requirements. In this way participants can practice using the sampling devices and 
ask questions.  There are several important points to emphasise about the 
methodology here; overlooking these points can invalidate the quality of data 
collected and rightly jeopardise opportunities to publish.  As pointed out in the 
section above only cortisol can be accurately measured following collection of saliva 
using salivette sampling devices.  These devices use a cotton swab to absorb saliva.  
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However both DHEA and melatonin stick to these swabs so for studies of these 
hormones it is necessary to collect saliva via fee drooling into small containers (e.g. 
Eppendorf tubes) cortisol can also be accurately measured from saliva collected 
using these devices. The other major consideration when measuring diurnal patterns 
of these hormones is to collect an adequate number of samples to enable analyses 
of the changing dynamics of secretion.  As these secretory dynamics are closely 
associated with sleep/wake patterns it is necessary to provide clear instructions on 
sample timing relative to individual awakening time.  This is especially true for 
cortisol as the CAR is a period of very rapid change in cortisol secretion, initiated at 
the moment of awakening.  Delay between awakening and collection of the first 
sample by as little of just over 5 minutes can generate inaccurate assessment 
(Smyth et al, 2013).  As participants are frequently not good at sampling within such 
a narrow time frame it has recently been agreed by a group of experts that electronic 
monitoring of awakening and sampling is a necessary requirement in CAR research 
(see Stalder et al, 2016).  Whilst this may seem demanding it is necessary when 
measuring the CAR.  In contrast the post-awakening patterns of melatonin and 
DHEA secretion are less volatile, and if measured without cortisol it is not necessary 
to employ these strict measures.  Likewise measurement of the day decline in all 
hormones, after the immediate post-awakening period, is less prone to the negative 
effects of moderate sampling delay. In this case self-reported diary records of 
awakening and sampling times is acceptable. However if morning samples are to be 
captured as part of the profile it is usual practice to instruct participants to collect 
samples in sets of hours post-awakening (e.g. 3,6,9,and 12 hours post awakening) 
rather than at set clock times.  This is necessary as there is the potential for large 
individual variation in awakening times between participants (e.g. 5.30am-10.00am). 
This means that a sample collected, say at 12.00 noon, could be much as 6.5hours, 
or as little as 2 hours, post awaking.  Interpretation of these values would be limited 
as the day decline would be ‘polluted’ with the CAR in the last instance, meaning the 
results for these 2 participants are not comparable. It is of course also necessary to 
abide by the rules of nil by mouth, other than water, for at least 30 minutes prior to 
each sampling.
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Although the diurnal patterns of these hormones are reported to be relatively 
reproducible from day to day it is strongly advisable to sample across at least 2 
typical weekdays in order to reliably capture the ‘typical’ or ‘trait-like’ profile of the 
individuals in the target populations. This is necessary to offset the possibility of 
random events interfering with underlying profiles. If using these hormone profiles as 
an outcome measure in an intervention evaluation it would be necessary to 
demonstrate that the difference between pre and post the intervention were greater 
than between 2 consecutive days.  For cortisol profiles this is especially a 
requirement when assessing the CAR, which has the most marked state variation of 
all measures considered here (see Stalder et al, 2016).
There is a wide and diverse literature on the relationship between diurnal patterns of 
these hormones (especially for cortisol) and physical and mental health outcomes.  
Whilst outside the scope of this brief chapter a common finding to emerge is that 
flattening of the diurnal profile of these hormones is associated with worse outcome, 
whatever that might be.  Indeed the consistent finding of flat cycles (i.e. less change 
in concentration from morning to evening (for cortisol and DHEA) and between day 
and night (for melatonin) is indicative of aging, chronic stress and morbidity in 
general (e.g. Stephton et al, 2000; Corbalan-Tutau et al, 2014, respectively).  
In summary careful assessment of the diurnal pattern of neuroendocrine function 
from saliva samples provides a useful insight into circadian function, dysregulation of 
which is a prominent factor in aging, chronic stress, physical and mental health 
disorders. 
Assessment of HPA axis reactivity 
The HPA axis response to an acute stress challenge has been associated with a 
range of stress-related disorders. For example in children and adolescents increased 
cortisol reactivity has been shown to be associated with behaviours and emotional 
problems associated with depression (Dockray et al, 2009). In contrast older patients 
with depression (mean age=62.3 years) have been reported to have an attenuated 
cortisol stress response (Taylor et al, 22006).  It has been proposed that chronic 
stress, with associated changes in HPA axis reactivity, is associated with changes in 
the structure and function of the hippocampus (via changes in neurogenesis) and 
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that this in turn leads to reduced negative feedback on the HPA axis, generating a 
vicious circle of psychopathology influential in the genesis of clinical depression (and 
a range of physical health conditions such as CV disease) (Mahar et al, 2014). Such 
theories makes it valuable to investigate individual differences in sensitivity of the 
HPA axis to stress-stimulation, as a marker of vulnerability to stress-related disorder. 
In laboratory settings acute activation of the HPA axis is typically studied by 
presenting individuals with a brief (~10 minute) psychosocial stressor. Protocols that 
contain the following elements (1) active engagement in the task (e.g. cognitive 
tasks, public-speaking or mental arithmetic); (2) lack of control; and (3) social-
evaluative threat (e.g. aspects of the ‘self’ appears to be negatively judged by others) 
are the most effective at eliciting a stress response (Dickerson & Kemeny, 2004). 
The most common and widely standardized protocol used is the Trier Social Stress 
Test (TSST). It includes a brief anticipation period and a 10 minute test period in 
which participants engage in a public speaking and mental arithmetic task in front of 
an unsympathetic authoritarian audience (Kirschbaum, Pirke, et al., 1993; Smyth et 
al., 2013 for an overview). Several studies have consistently demonstrated that the 
TSST produces large and reliable HPA axis responses in both healthy and clinical 
populations (Dickerson & Kemeny, 2004; Kirschbaum, Pirke, et al., 1993; McRae et 
al., 2006). Typically, cortisol has been the main physiological measure of interest 
however, more recently, the importance of DHEA and DHEA-S have been 
highlighted. To our knowledge melatonin has not been studied in this context. 
Activation of the HPA axis in response to stress is immediate, but the peak of cortisol 
secretion is reached approximately 30 minutes following onset of the stressor, 
returning to baseline in the following hour (Dickerson & Kemeny, 2004). Less focus 
has been on the secretion of DHEA/DHEA-S in response to psychosocial stressors, 
however, studies that have investigated this show that on average plasma and 
salivary DHEA/DHEA-S peaks 20 min following onset of the stressor (Izawa et al., 
2008; Lennartsson et al., 2012) and returns to baseline levels 40-50 min following 
the stressor (Izawa et al., 2008). DHEA responses have been shown to be 
moderately associated with cortisol (Izawa et al., 2008). The finding that DHEA 
activation precedes cortisol by approximately 10 min (Izawa et al., 2008; 
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Lennartsson et al., 2012) is surprising since the secretion of these hormones are 
dependent upon the same secretagoge: ACTH. The time difference might reflect 
differential latency in steroidogenic pathways. ACTH stimulates the first step 
(cholesterol to pregnenolone).  Subsequent conversion to DHEA involves fewer 
enzyme-mediated biosynthetic stages than the cortisol pathway. Due to changes in 
basal levels of both DHEA and cortisol in the morning (Hucklebridge et al, 2005) and 
the post-prandial period (e.g. Lovallo et al., 2005; Svec & Shawar, 1997) it is 
recommended that stress reactivity testing takes place in the afternoon (at least 1 
hour after lunch) and time of testing should be consistent throughout the study 
(Dickerson & Kemeny, 2004; Kudielka et al., 2004). To capture the full profile of the 
stress response and the peak of cortisol or DHEA saliva samples should be collected 
at 10–15 min before and immediately prior to the stressor onset and again 10- to 15-
min intervals for about 45–60 min after the end of the stressor (Kirschbaum, Pirke, et 
al., 1993). Following food, drink, physical exercise or smoking cortisol and DHEA 
levels increase (e.g. Lovallo et al., 2005; Svec & Shawar, 1997; Mendelson et al., 
2005; Kirschbaum et al., 1992), thus participants should remain nil-by-mouth (except 
water) and free from exercise for 30 min prior to saliva sampling period. 
More recently a group version of the TSST has been developed and found to reliably 
activate the HPA axis: TSST-G (von Dawans et al. 2011).  The same elements of 
motivated task performance, lack of control and socioevaluative threat are in place 
however, instead of individual testing, 6 participants are tested together, in 
sequence.  In turn, each participant gives a 2 minute talk, after which each 
participant completes the mental arithmetic task for 80 seconds.  This version of the 
TSST may be of particular interest to experimental social psychologists as it is 
possible to manipulate the social context of the groups, e.g. to examine the impact of 
social identity (e.g. Häusser et al, 2012).  It has also been used to examine individual 
differences in stress reactivity without social manipulation (Smyth et al, 2015).  
When studying stress reactivity in relation to psychological individual difference 
variables it is important to take account of various demographic and developmental 
factors, which if ignored might contaminate data analysis. Table 1 provides a brief 
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overview of such factors when examining cortisol and DHEA responses to stress.  
The table includes initial basal levels, when relevant, as well as responsivity. 
Table 7.1. Some variables to consider when measuring salivary cortisol and DHEA 
responses to stress 
(a) Cortisol (b) DHEA 
Age • Studies show that older 
adults have higher basal 
cortisol levels and some 
show an enhanced 
response to psychosocial 
stressor Kudielka 1999; 
Nicolson, 1997) but 
findings are mixed 
(Kudielka, 2004; Rohleder, 
2002). 
• DHEA basal levels are 
age dependent: from 1 
month old levels decline, 
rise to mark the onset of 
adrenarche, peaking 
between 20-40 years old 
and decline thereafter 
reaching lowest levels 
between 70-80 years old, 
at approximately 20-30% 
of peak levels. (Kroboth et 
al., 1999). 
• Magnitude of 
DHEA/DHEA-S stress 
response is reduced with 
age (Lennartsson et al., 
2012).
Gender • Males reliably show larger 
responses (e.g. 200-400% 




{Kudielka et al, 2009). 
• Basal levels are lower in 
males compared with females 
(see Kroboth et al., 1999). 
• No significant differences 
between males and females 
in DHEA stress reactivity 
levels. For DHEA-S increases 
were significantly higher for 
males (ranging from 5% to 
47%) compared with females 
(ranging from 2% to 40%) 
(Lennartsson et al., 2012). 
Menstrual 
Cycle 
• Larger responses observed 
during the luteal phase 
whilst smaller responses in 
• Self-reported menstrual 
phase did not affect DHEA 
levels or response patterns 
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the follicular phase or in 
women taking oral 
contraceptives (Kudielka et 
al, 2009) 




• The cortisol response to a 
psychological stressor is 
associated with the 
transition to adolescence:  
blunted in boys and 
increased in girls {Gunnar, 
2009 #1349}. 
• DHEA and DHEA-S secretion 
rises rapidly during puberty in 
both boys and girls (Smith 
1975). 
• Higher DHEA levels observed 
in older and more puberty 
advanced adolescences and 
this effect is more 
pronounced in girls compared 
with boys (Shirtcliff et al., 
2007).
• Mixed results that DHEA 
responsively to stressors are 
associated with age and 
puberty e.g. higher DHEA 
responses in adolescents 
more puberty developed for a 
public speaking task but not 
in the conflict discussion 




• Blunted stress responses 
associated with chronic 
alcohol consumption 
{Lovallo, 2000 #1352}. 
• Results for social drinkers 
and those with a family 
history more mixed (see 
Kudielka et al 2009). 
• In students that binge drink, 
DHEA levels did not 
significantly increase 
following a stressor 
(impossible task) (Wemm et 
al., 2013). 
Smoking • Habitual smokers have 
chronically elevated 
cortisol levels but a blunted 
response to a standardised 
stressor (Kudielka et al, 
• High doses of nicotine 
induces elevated DHEA 
levels (Mendelson et al., 
2005). 
• DHEA levels are higher in 
16
2009). smokers compared with non-
smokers Nonsmokers 
(Pomerleau et al, 1992; Field 
et al, 1994; del Arbol et al, 
2000; al’Absi et al, 2003).
Medication • Medication use should be 
recorded – numerous and 
ever-changing range of 
medications impact on 
salivary cortisol, see 
Granger et al {, 2009 
#1361} for the pathways 
involved.  
• Medications can impact 
cortisol responses to 
psychological stressors in 
both patients and healthy 




• Medication use should be 
recorded – numerous and 
ever-changing range of 
medications impact on DHEA 
levels, see Kroboth et al. 
(1999) for an overview. 
Physical 
exercise 
• Review?? Or key study? • Exercise is associated with 
higher basal DHEA (see 
Kroboth et al., 1999).
Conclusions
In conclusion, the development of salivary assays for cortisol, DHEA and melatonin 
determination has provided the opportunity to gain valuable insight into individual 
differences in circadian rhythms and stress reactivity. The ease and widespread 
acceptability of saliva sampling has enabled the study of small infants to the very old.  
Differences in circadian function and/or stress reactivity can be detectable prior 
clinical manifestation of symptoms. Such observations enable the development of 
theoretical frameworks centered on stress-related vulnerability that can be tested in 
longitudinal lifespan studies and inform a wide range of physical and mental health 
clinical syndromes. The use of saliva samples in this way is relatively simple and 
attention to the methodological considerations summarized in this chapter will ensure 
the validity of results generated and hence help advance this fascinating and 
important area of research. 
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